CHICAGO / TUMKUR. Jan. 25, 2012. Dr. Shiraz Ahamed Sharief has been invited to the 20th Ainshams International Medical Students’ Congress to be held at Cairo-Egypt between February 25 and 28, 2012. It is organized by Ainshams University Students’ Scientific Society.
Dr. Shiraz will present a paper on Post-ERCP Pancreatitis. Hailing from Tumkur in Karnataka, he is the son of Alhaj K. Nayaz Ahamed. Dr. Shiraz did his MBBS from Rajiv Gandhi University of Health Sciences with First Class.
The abstract of his presentation:
“Evaluating the Risk Factors in Post – Endoscopic Retrograde Cholangio Pancreatiography (Post-E.R.C.P) Pancreatitis.” By Dr. Shiraz Ahamed Sharief MBBS, MS (Gen. Surgery) Resident Member, American College of Surgeons, Chicago
Introduction: ERCP is a diagnostic and therapeutic procedure, used often for pancreatic and biliary pathologies. It combines both endoscopic and fluoroscopic methods. Even though it has wider applications, the complications should not be under estimated. Acute pancreatitis is one among the complications, which is most common and sometimes severe. This study evaluated the various potential risks, and pancreatitis as an outcome following ERCP procedure.
Methods: A retrospective study was conducted in two different pancreatico biliary centres during January 2010 to January 2012. A predetermined questionnaire with investigations, prior to ERCP and post procedure outcomes were evaluated.
- A total of 285 patients underwent ERCP, 167 (58.6%) were diagnostic (Dx) and 118 (41.4%) were therapeutic (Rx) procedures.
- 28 patients (net 9.8%) developed pancreatitis, among them :
- 9/167 (5.4%) were during Dx-ERCP and 19/118 (16.1%) were during Rx-ERCP (approx. 3 times more).
- 12/132 (9.9%) were male patients and 16/153 (10.5%) were female patients.
- 11/140 (7.9%) were more than 55 years, 17/145 (11.7%) were less than 55 years.
- 22/267 (8.2%) patients had no previous H/O of ERCP, 6/18 (33.3%) patients had H/O of previous ERCP (approx. 4 times more).
- 19/216 (8.8%) patients had no previous H/O pancreatitis, 9/69 (13.0%) patients had past H/O of pancreatitis (approx. 1.5 times more).
- 9/129 (7.0%) patients had no previous H/O alcoholism, 19/156 (12.02%) patients had past H/O of alcoholism (approx. 1.7 times more).
- 11/187 (5.9%) patients had no sphincter of Oddi dysfunction. 17/98 (17.3%) patients had sphincter of Oddi dysfunction (approx. 3 times more).
- 16/201 (7.9%) patients had single contrast injection, 12/84 (14.3%) patients had multiple contrast injections, (approx. 1.8 times more).
Conclusion: From this research study, various risk factors have been analyzed. It should be kept in mind that, more the risk factors, greater the possibility of post ERCP pancreatitis, hence the ideal patient should be preferred with least risk factors. Unnecessary procedures should be discouraged, especially when the patient has multiple risks. Also all the patients who are undergoing ERCP should be informed about the potential complication of developing pancreatitis and its future outcome.